Investors Attracted to New CBD Pharmaceutical Company – Elemental Pharma, Inc.

CBD Pharmaceutical Company Manufacturing Facilities Approved by the FDA

ATLANTA, GA / ACCESSWIRE / January 27, 2020 / HempCBD Investor Magazine https://joom.ag/jpOe, the leading industry investment magazine for Hemp and CBD investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published Issue #2 https://joom.ag/jpOe, which is free to subscribers who enter their email address and phone number.

Issue #2 https://joom.ag/jpOe features Elemental Pharma, Inc. a vertically integrated CBD pharmaceutical company which grows hemp, manufactures CBD pharmaceuticals and distributes them to its pharmacy network.

Elemental Pharma's extraction facilities currently harvest 55,000 kilos of biomass a year. The company's manufacturing facilities are approved by the United States Food and Drug Administration and the company has received approvals for OTC, White Label, Wholesale and FDA registered brands.

The company currently has eight wholly owned subsidiaries and a highly experienced management team with combined experience of more than 100 years. Since its establishment, Elemental Pharma has developed over 150 sales channels and generated revenues of approximately $9 million in 2019. To view Elemental Pharma's feature in the HempCBD Investor Magazine please click on this link https://joom.ag/jpOe. For investor inquiries, please contact Keith M. Spears at keithmspears@gmail.com or (415) 694-3520.

About HempCBD Investor Magazine

HempCBD Investor Magazine is a monthly subscription based digital magazine with an exclusive focus on Hemp and CBD finance that delivers convenient insights on publicly traded and privately held industry companies through informative articles, company profiles, and market trends that inform and educate global investors. For more information about HempCBD Investor Magazine please visit our websites www.cannainvestormag.com and www.cannainvestormag.ca.

Contact:

Investor Webcast & Magazine, Inc.
D.A. Wallace
1-888-575-1254, Ext. 1
team@cannainvestormag.com
team@cannainvestormag.ca

SOURCE: Cannabis Investor Magazine

ReleaseID: 574193